Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Nilsson Håkan) "

Sökning: WFRF:(Nilsson Håkan)

Sortera/gruppera träfflistan
  • Sjölund, Katarina, et al. (författare)
  • Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.
  • 2010
  • Ingår i: World journal of surgery. - : Springer Science and Business Media LLC. - 1432-2323 .- 0364-2313. ; 34:9, s. 2090-2097
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Gastrointestinal stromal tumors (GISTs) express the receptor tyrosine kinase KIT. Most GISTs have mutations in the KIT or PDGFRA gene, causing activation of tyrosine kinase. Imatinib, a tyrosine kinase inhibitor (TKI), is the first-line palliative treatment for advanced GISTs. Sunitinib was introduced for patients with mutations not responsive to imatinib. The aim was to compare the survival of patients with high-risk resected GISTs treated with TKI prior to surgery with historical controls and to determine if organ-preserving surgery was facilitated. METHODS: Ten high-risk GIST-patients had downsizing/adjuvant TKI treatment: nine with imatinib and one with sunitinib. The patients were matched with historical controls (n = 89) treated with surgery alone, from our population-based series (n = 259). Mutational analysis of KIT and PDGFRA was performed in all cases. The progression-free survival was calculated. RESULTS: The primary tumors decreased in mean diameter from 20.4 cm to 10.5 cm on downsizing imatinib. Four patients with R0 resection and a period of adjuvant imatinib had no recurrences versus 67% in the historical control group. Four patients with residual liver metastases have stable disease on continuous imatinib treatment after surgery. One patient has undergone reoperation with liver resection. The downsizing treatment led to organ-preserving surgery in nine patients and improved preoperative nutritional status in one patient. CONCLUSIONS: Downsizing TKI is recommended for patients with bulky tumors with invasion of adjacent organs. Sunitinib can be used for patients in case of imatinib resistance (e.g., wild-type GISTs), underlining the importance of mutational analysis for optimal surgical planning.
  • Arne, Gabriella, et al. (författare)
  • Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location, and poor prognosis.
  • 2011
  • Ingår i: International journal of cancer. Journal international du cancer. - : Wiley. - 1097-0215 .- 0020-7136. ; 129:5, s. 1149-1161
  • Tidskriftsartikel (refereegranskat)abstract
    • In gastrointestinal stromal tumors (GISTs), KIT exon 11 deletions are associated with poor prognosis. The aim of this study was to determine the gene expression profiles of GISTs carrying KIT exon 11 deletions and to identify genes associated with poor prognosis. Expression profiling was performed on 9 tumors with KIT exon 11 deletions and 7 without KIT exon 11 mutations using oligonucleotide microarrays. In addition, gene expression profiles for 35 GISTs were analyzed by meta-analysis. Expression of CD133 (prominin-1) protein was examined by tissue microarray (TMA) analysis of 204 GISTs from a population-based study in western Sweden. Survival analysis was performed on patients subjected to R0 resection (n=180) using the Cox proportional hazards model. Gene expression profiling, meta-analysis, and qPCR showed up regulation of CD133 in GISTs carrying KIT exon 11 deletions. Immunohistochemical analysis on TMA confirmed CD133 expression in 28% of all tumors. CD133 positivity was more frequent in gastric GISTs (48%) than in small intestinal GISTs (4%). CD133 positivity was also more frequent in GISTs with KIT exon 11 mutations (41%) than in tumors with mutations in KIT exon 9, PDGFRA, or wild-type tumors (0-17%). Univariate survival analysis showed a significant correlation between the presence of CD133 protein and shorter overall survival (hazard ratio=2.23, P=0.027). Multivariate analysis showed that CD133 provided additional information on patient survival compared to age, sex, NIH risk group and mutational status. CD133 is expressed in a subset of predominantly gastric GISTs with KIT exon 11 mutations and poor prognosis.
  • Arne, Gabriella, et al. (författare)
  • Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.
  • 2013
  • Ingår i: Acta oncologica (Stockholm, Sweden). - 1651-226X .- 0284-186X. ; 52:4, s. 783-792
  • Tidskriftsartikel (refereegranskat)abstract
    • Background. Gastrointestinal stromal tumors (GISTs) can be effectively treated with tyrosine kinase inhibitors (TKIs). However, some patients with GIST develop drug resistance, and alternative treatment strategies are therefore needed. The aim of this study was to analyze the expression of somatostatin receptors (SSTR) in GIST as a target for peptide receptor-mediated radiotherapy (PRRT). Material and methods. Expression profiling of SSTR1-5 was performed on biopsies from 34 GISTs (16 gastric tumors, 15 small intestinal tumors, and three rectal tumors). SSTR scintigraphy ((111)In-octreotide) and measurement of (111)In activity in tumor specimens was performed in seven patients. Uptake and internalization of (177)Lu- octreotate was studied in primary cell cultures from two patients. Results. Quantitative PCR analysis showed expression of SSTR1 and SSTR2 in the majority of tumors, while SSTR3-5 were expressed at low levels. Immunohistochemical analysis confirmed the presence of SSTR1 and SSTR2 proteins in all GISTs, and SSTR3-5 in a subset of tumors. Diagnostic imaging by SSTR scintigraphy, using (111)In-octreotide, demonstrated tumor uptake of (111)In in three of six GIST patients. Measurement of (111)In activity in excised tumor specimens from five patients gave tumor-to-blood (T/B) activity ratios of between eight and 96. Tumor cells in primary culture (gastric and small intestinal GIST) specifically bound and internalized (177)Lu when incubated with the therapeutic compound (177)Lu-octreotate for 4-48 hours (p < 0.05). Conclusion. Peptide receptor-mediated radiotherapy via SSTR may provide a novel treatment strategy in carefully selected GIST patients with TKI-resistant tumors.
  • Balkhed Östholm, Åse, 1972-, et al. (författare)
  • Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study
  • 2018
  • Ingår i: PLOS ONE. - : Public Library of Science. - 1932-6203. ; 13:10
  • Tidskriftsartikel (refereegranskat)abstract
    • In a previous study, we found that 30% of individuals travelling outside Scandinavia acquired extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in their faecal flora. The aim of this study was to determine the duration of travel-associated faecal colonisation with ESBL-PE, to assess risk factors for prolonged colonisation and to detect changes in antibiotic susceptibility during prolonged colonisation.
  • Berglund, Björn, et al. (författare)
  • Clonal spread of carbapenem-resistant Klebsiella pneumoniae among patients at admission and discharge at a Vietnamese neonatal intensive care unit
  • 2021
  • Ingår i: Antimicrobial Resistance and Infection Control. - : BMC. - 2047-2994. ; 10:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Background The increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is a growing problem globally, particularly in low- to middle-income countries (LMICs). Previous studies have shown high rates of CRE colonisation among patients at hospitals in LMICs, with increased risk of hospital-acquired infections. Methods We isolated carbapenem-resistant Klebsiella pneumoniae (CRKP) from faecal samples collected in 2017 from patients at admission and discharge at a Vietnamese neonatal intensive care unit (NICU). 126 CRKP were whole-genome sequenced. The phylogenetic relationship between the isolates and between clinical CRKP isolates collected in 2012-2018 at the same hospital were investigated. Results NDM-type carbapenemase-(61%) and KPC-2-encoding genes (41%) were the most common carbapenem resistance genes observed among the admission and discharge isolates. Most isolates (56%) belonged to three distinct clonal clusters of ST15, carrying bla(KPC-2), bla(NDM-1) and bla(NDM-4), respectively. Each cluster also comprised clinical isolates from blood collected at the study hospital. The most dominant ST15 clone was shown to be related to isolates collected from the same hospital as far back as in 2012. Conclusions Highly resistant CRKP were found colonising admission and discharge patients at a Vietnamese NICU, emphasising the importance of continued monitoring. Whole-genome sequencing revealed a population of CRKP consisting mostly of ST15 isolates in three clonally related clusters, each related to blood isolates collected from the same hospital. Furthermore, clinical isolates collected from previous years (dating back to 2012) were shown to likely be clonally descended from ST15 isolates in the largest cluster, suggesting a successful hospital strain which can colonise inpatients.
  • Berglund, Björn, et al. (författare)
  • Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam
  • 2018
  • Ingår i: International Journal of Antimicrobial Agents. - : ELSEVIER SCIENCE BV. - 0924-8579 .- 1872-7913. ; 51:5, s. 789-793
  • Tidskriftsartikel (refereegranskat)abstract
    • Resistance among Klebsiella pneumoniae to the last-resort antibiotics carbapenems and colistin is increasing worldwide. In this study, whole-genome sequencing was used to determine the colistin resistance mechanisms in clinical isolates of carbapenem-and colistin-resistant K. pneumoniae from Vietnam. Alterations in the regulatory gene mgrB, via mutations and insertion sequence transpositions, were found in 30 of 31 isolates, emphasising the importance of this resistance mechanism in colistin-resistant K. pneumoniae. (c) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
  • Bümming, Per, 1965, et al. (författare)
  • Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
  • 2008
  • Ingår i: Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. - : Springer Science and Business Media LLC. - 1435-2443. ; 393:5, s. 699-703
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND AND AIMS: Patients with sporadic medullary thyroid carcinoma (MTC) have a variable clinical course. Our aim was to analyse the reduction of tumour markers after thyroidectomy with meticulous dissection and relate it to clinical outcome. MATERIALS AND METHODS: Twenty consecutive patients with palpable sporadic MTC underwent thyroidectomy with central and uni- or bilateral modified radical neck dissection; three were subjected to mediastinal dissection. Basal (b-) and stimulated (s-) calcitonin (CT) and carcinoembryonic antigen (CEA)-levels were measured before and 6-8 weeks after primary surgery, and the reduction of these tumour markers was determined. RESULTS: Median CT (b- and s-) were markedly reduced after surgery (98.5% and 99.1%, respectively), and CEA decreased 11 times. CT (b-) fell >99% in seven patients after surgery; in these and four additional patients, CT (s-) showed a similar reduction. During follow-up (median 52.5 months), two patients (stages IV B and C) died of MTC; they had <95% reduction of CT. Four patients (stage IV A) are alive with verified metastases. Eight patients (one stage III, seven stage IV A) are alive with hypercalcitoninemia. Five stages I-III patients and one stage IV A patient are disease-free. CONCLUSIONS: Thyroidectomy and meticulous dissection caused a pronounced reduction of tumour markers. A postoperative reduction of CT (s-) >/=97% seems to be associated with less aggressive clinical course, while CEA had lower predictive value.
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (717)
konferensbidrag (294)
bokkapitel (98)
rapport (65)
doktorsavhandling (39)
annan publikation (31)
visa fler...
forskningsöversikt (15)
konstnärligt arbete (10)
bok (10)
licentiatavhandling (10)
samlingsverk (redaktörskap) (7)
proceedings (redaktörskap) (2)
patent (2)
recension (2)
visa färre...
Typ av innehåll
refereegranskat (920)
övrigt vetenskapligt/konstnärligt (255)
populärvet., debatt m.m. (117)
Nilsson, Håkan (168)
Nilsson, Håkan, 1971 (156)
Ahlman, Håkan, 1947 (126)
Nilsson, Ola, 1957 (118)
Wängberg, Bo, 1953 (85)
Johansson, Håkan T, ... (73)
visa fler...
Nilsson, Thomas, 196 ... (72)
Simon, H (59)
Aumann, T (57)
Boretzky, K. (57)
Reifarth, R (55)
Jonson, Björn, 1941 (50)
Cortina-Gil, D. (50)
Paschalis, S. (49)
Forssell-Aronsson, E ... (47)
Rossi, D (46)
Geissel, H. (46)
Weick, H. (46)
Heil, M (44)
Plag, R (44)
Langer, C. (43)
Wamers, F. (41)
Le Bleis, T. (40)
Chartier, M. (39)
Alvarez-Pol, H. (39)
Tengblad, O (38)
Kölby, Lars, 1963 (38)
Nociforo, C. (38)
Frantzich, Håkan (38)
Kurz, N (37)
Nilsson, Daniel (37)
Panin, V. (37)
Perea, A. (37)
Caesar, C (34)
Ershova, O. (33)
Chulkov, L. V. (32)
Savran, D. (32)
Scheit, H. (32)
Olsson, Håkan (31)
Hanberger, Håkan (31)
Emling, H. (31)
Galaviz, D. (30)
Heinz, Andreas Marti ... (29)
Borge, M. J. G. (29)
Marganiec, J (28)
Chatillon, A. (28)
Riisager, K. (28)
Nilsson, Mats (27)
Mahata, K. (27)
Casarejos, E. (27)
visa färre...
Lunds universitet (287)
Chalmers tekniska högskola (253)
Göteborgs universitet (209)
Uppsala universitet (145)
Umeå universitet (111)
Linköpings universitet (110)
visa fler...
Södertörns högskola (92)
Karolinska Institutet (54)
Luleå tekniska universitet (44)
Jönköping University (41)
Sveriges Lantbruksuniversitet (40)
Högskolan Väst (37)
Mittuniversitetet (25)
Kungliga Tekniska Högskolan (24)
Stockholms universitet (24)
RISE (23)
Högskolan i Gävle (22)
Örebro universitet (19)
Blekinge Tekniska Högskola (17)
Högskolan i Skövde (16)
Linnéuniversitetet (14)
Malmö universitet (13)
Högskolan i Halmstad (11)
Handelshögskolan i Stockholm (11)
VTI - Statens väg- och transportforskningsinstitut (11)
Gymnastik- och idrottshögskolan (5)
Naturvårdsverket (4)
Karlstads universitet (4)
Konstfack (3)
Högskolan i Borås (2)
Försvarshögskolan (2)
Högskolan Kristianstad (1)
Högskolan Dalarna (1)
IVL Svenska Miljöinstitutet (1)
Röda Korsets Högskola (1)
visa färre...
Engelska (1088)
Svenska (194)
Odefinierat språk (7)
Franska (2)
Tyska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (376)
Teknik (313)
Naturvetenskap (227)
Samhällsvetenskap (145)
Humaniora (116)
Lantbruksvetenskap (40)


Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy